Why the AVITA Medical share price is up 575% in 2019

The AVITA Medical Ltd (ASX:AVH) share price stormed to a multi-year high today and stretched its year to date gain to a staggering 575%…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The AVITA Medical Ltd (ASX: AVH) share price continued its incredible run on Tuesday.

In fact, at one stage today the Avita Medical share price was up almost 29% to a multi-year high of 54 cents.

When its shares reached this level it stretched their year to date gain to a remarkable 575%.

What is AVITA Medical?

AVITA Medical is a global regenerative medicine company that provides a novel approach to skin regeneration.

Its products provide innovative treatment solutions which are derived from the regenerative properties of a patient's own skin.

In addition to this, the company's proprietary technology has evidence for other skin applications beyond treating burns, such as chronic and traumatic wounds, scar revision, and vitiligo.

Why is the AVITA Medical share price on fire this year?

Investors have been fighting to get hold of the company's shares due to the potential of its RECELL System, which is a regeneration platform which was approved by the U.S. FDA late last year as a Class III device for the treatment of acute thermal burns.

RECELL was designed by surgeons and is described as being an elegant means to deliver skin regeneration to patients at point of care.

It has proven safety and effectiveness. The system has over 8,000 uses to date in multiple world markets and no observed safety signals. And in respect to effectiveness, the treatment area is a whopping 80x the donor area. This means that a skin sample the size of credit card can be used to treat a patient's entire back.

Another positive is that RECELL provides significant savings to burn centres. According to a recent presentation, a burn centre with 200 patients could reduce treatment costs by almost a third if they used RECELL.

This appears to have many investors believing the company is well-positioned to generate significant revenue in a U.S. market estimated to be worth US$5.7 billion per year at present.

In addition to this, the company has its eyes on a Vitiligo market estimated to be worth US$2 billion per year and the Skin Aesthetics market which is estimated to be worth US$22 billion per year.

Should you invest?

I think AVITA Medical is an exciting company and well worth keeping a close eye on. But with its market capitalisation nearing $900 million and revenue still reasonably limited, I'm going to sit this one out for now.

Instead, I think CSL Limited (ASX: CSL) and even Mayne Pharma Group Ltd (ASX: MYX) shares could be good alternatives.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »